{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:18Z","timestamp":1790739798382,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.pupt.2022.102146","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T17:40:21Z","timestamp":1658252421000},"page":"102146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of intrapleural fibrinolytic therapy and dosing strategies used for complicated pleural effusions"],"prefix":"10.1016","volume":"76","author":[{"given":"Laura","family":"Baumgartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2022.102146_bib1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.TA.0000141879.67441.52","article-title":"Intrapleural tissue plasminogen activator for complicated pleural effusions","volume":"54","author":"Skeete","year":"2004","journal-title":"J. Trauma Inj. Infect. Crit. Care"},{"key":"10.1016\/j.pupt.2022.102146_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/thx.58.suppl_2.ii18","article-title":"BTS guidelines for the management of pleural infection","volume":"58","author":"Davies","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2022.102146_bib3","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.rmed.2008.08.012","article-title":"Recombinant tissue plasminogen activator in the treatment of pleural infections in adults","volume":"102","author":"Froudarakis","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2022.102146_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1378\/chest.119.5.1547","article-title":"Resolution of pleural effusions","volume":"119","author":"Cohen","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2022.102146_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000117172","article-title":"Parapneumonic pleural effusions and empyema","volume":"75","author":"Koegelenberg","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2022.102146_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM195501202520301","article-title":"Pleural effusion: a statistical study of 436 patients","volume":"252","author":"Leuallen","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2022.102146_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3322\/canjclin.22.3.138","article-title":"Management of recurrent malignant effusions","volume":"22","author":"Dollinger","year":"1972","journal-title":"A Cancer Journal for Clinicians"},{"key":"10.1016\/j.pupt.2022.102146_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3322\/canjclin.41.3.166","volume":"41","author":"Ultmann","year":"1991","journal-title":"Malignant Effusions. A Cancer Journal for Clinicians"},{"key":"10.1016\/j.pupt.2022.102146_bib9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0003-4975(97)00899-0","article-title":"Early evacuation of traumatic retained hemothoraces using thoracoscopy: a prospective randomized trial","volume":"64","author":"Meyer","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.pupt.2022.102146_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00068-002-1264-2","article-title":"Posttraumatic empyema","volume":"6","author":"Hoth","year":"2002","journal-title":"Eur. J. Trauma"},{"key":"10.1016\/j.pupt.2022.102146_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.athoracsur.2010.10.082","article-title":"Effectiveness and risks associated with intrapleural alteplase by means of tube thoracostomy","volume":"91","author":"Ben-Or","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.pupt.2022.102146_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archsurg.133.6.637","article-title":"Video assisted thoracic surgery in the treatment of posttraumatic empyema","volume":"133","author":"Scherer","year":"1998","journal-title":"Arch. Surg."},{"issue":"2","key":"10.1016\/j.pupt.2022.102146_bib13","first-page":"1","article-title":"Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema","author":"Cameron","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2022.102146_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2012.02.005","article-title":"A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions","volume":"106","author":"Thommi","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2022.102146_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/ajrccm\/144.1.187","article-title":"Abnormalities of pathways of fibrin turnover in the human pleural space","volume":"144","author":"Idell","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2022.102146_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1183\/09031936.95.08081352","article-title":"Fibrinolytic and inflammatory processes in pleural effusions","volume":"8","author":"Philip","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2022.102146_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20030115","article-title":"Association between inflammatory and the fibrinolysis system in infectious pleural effusions","volume":"105","author":"Aleman","year":"2003","journal-title":"Clin. Sci."},{"key":"10.1016\/j.pupt.2022.102146_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.mcp.0000129755.79467.67","article-title":"Recent advances in parapneumonic effusions and empyema","volume":"10","author":"Chapman","year":"2004","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.pupt.2022.102146_bib18a","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0160-9963(00)80118-1","article-title":"The use of fibrinolytic agents in drainage of complicated fluid collections","volume":"27","author":"Safvi","year":"1998","journal-title":"Appl. Radiol."},{"key":"10.1016\/j.pupt.2022.102146_bib18b","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.mjt.0000208275.88120.d1","article-title":"Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema","volume":"14","author":"Thommi","year":"2007","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.pupt.2022.102146_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.pupt.2022.102146_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.20344\/amp.7178","article-title":"Fibrinolytics in the treatment of complicated pleural effusions","volume":"29","author":"Coelho","year":"2016","journal-title":"Acta Medica Portugesa"},{"issue":"2","key":"10.1016\/j.pupt.2022.102146_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/LBR.0000000000000265","article-title":"Intrapleural fibrinolytic therapy in patients with nondraining indwelling pleural Catheters","volume":"23","author":"Vial","year":"2016","journal-title":"Journal of Bronchology & Interventional Pulmonology"},{"key":"10.1016\/j.pupt.2022.102146_bib23","article-title":"Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections","author":"McClune","year":"2016","journal-title":"Can. Respir. J. J. Can. Thorac. Soc."},{"issue":"2","key":"10.1016\/j.pupt.2022.102146_bib24","article-title":"Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions\u2014analysis of predictors for failure of therapy and bleeding: a cohort study","volume":"3","author":"Saleh","year":"2013","journal-title":"BMJ Open"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553922000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553922000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:30:56Z","timestamp":1761082256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553922000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":25,"alternative-id":["S1094553922000372"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2022.102146","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of intrapleural fibrinolytic therapy and dosing strategies used for complicated pleural effusions","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2022.102146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102146"}}